Bristol Myers Squibb's European Research & Development operations have been based here since 2003. Employees work in eight buildings located in an office park set in the countryside.

In Cambridge, Bristol Myers Squibb scientists will focus on the company’s ongoing discovery efforts, molecular discovery technologies and discovery platform chemistry in state-of-the-art lab space. The new research site is expected to open in 2018.

Acquired in 1997, some of the company's most important drug discovery work takes place at this 433-acre site. Eight major buildings reside on the site, totaling 800,000 square feet.

The 11.2 acre research facility is located on the Wirral Peninsula between Chester and Liverpool. Scientists here investigate new medicinal compounds and how they can be manufactured efficiently on a commercial scale.

Purchased in 1905 when E.R. Squibb & Sons relocated operations from Brooklyn, New York, this campus has 40 buildings that total 1.9 million square feet on 96 acres. The site has evolved from a manufacturing site to become Bristol Myers Squibb's center for excellence for our therapeutic compounds.

The newly constructed 650,000-square foot facility opened November 2016 and houses employees from the Commercial teams, their commercialization and late-stage development partners from Research & Development and Global Manufacturing & Supply and their enabling function support teams.

The 276-acre campus serves as Bristol Myers Squibb's Research and Development headquarters. Here scientists discover and develop medicines in the areas of cancer, immunology, and cardiovascular diseases. The campus has 13 connected buildings totaling 1.5 million square feet.

Bristol Myers Squibb's European and French headquarters located 45 minutes from downtown Paris. The building, opened in August 2002, was designed by internationally recognized architect Jean-Paul Viguier.

The 256,000 square-foot Bay Area research facility houses biologics drug discovery activities focused on antibody therapeutics. The Redwood City location provides proximity to major biomedical research centers such as University of California Berkeley, University of California San Francisco and Stanford University.

Since 1995, Bristol Myers Squibb has occupied 76,000 square feet of an office building in Nishi-Shinjuku, Tokyo.